A detailed history of Black Rock Inc. transactions in Galapagos Nv stock. As of the latest transaction made, Black Rock Inc. holds 560,358 shares of GLPG stock, worth $17.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
560,358
Previous 519,291 7.91%
Holding current value
$17.1 Million
Previous $16.7 Million 16.96%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$24.78 - $32.48 $1.02 Million - $1.33 Million
41,067 Added 7.91%
560,358 $13.9 Million
Q1 2024

May 10, 2024

BUY
$32.2 - $42.44 $1.8 Million - $2.38 Million
56,031 Added 12.09%
519,291 $16.7 Million
Q4 2023

Feb 13, 2024

BUY
$31.87 - $40.71 $722,014 - $922,285
22,655 Added 5.14%
463,260 $18.8 Million
Q3 2023

Nov 13, 2023

SELL
$34.17 - $42.98 $1.41 Million - $1.77 Million
-41,258 Reduced 8.56%
440,605 $15.2 Million
Q2 2023

Aug 11, 2023

BUY
$37.4 - $44.52 $93,126 - $110,854
2,490 Added 0.52%
481,863 $19.6 Million
Q1 2023

May 12, 2023

SELL
$36.5 - $48.0 $554,398 - $729,072
-15,189 Reduced 3.07%
479,373 $18.5 Million
Q4 2022

Feb 13, 2023

BUY
$37.44 - $46.51 $480,654 - $597,095
12,838 Added 2.67%
494,562 $21.9 Million
Q3 2022

Nov 14, 2022

SELL
$42.27 - $57.6 $1.45 Million - $1.98 Million
-34,309 Reduced 6.65%
481,724 $20.5 Million
Q2 2022

Aug 12, 2022

SELL
$52.3 - $71.59 $82,529 - $112,969
-1,578 Reduced 0.3%
516,033 $28.8 Million
Q1 2022

May 12, 2022

BUY
$51.32 - $68.5 $8.46 Million - $11.3 Million
164,912 Added 46.76%
517,611 $32.1 Million
Q4 2021

Feb 10, 2022

SELL
$47.03 - $57.12 $1.74 Million - $2.12 Million
-37,060 Reduced 9.51%
352,699 $19.4 Million
Q3 2021

Nov 09, 2021

SELL
$52.17 - $70.2 $908,592 - $1.22 Million
-17,416 Reduced 4.28%
389,759 $20.5 Million
Q2 2021

Aug 11, 2021

BUY
$68.86 - $83.34 $28 Million - $33.9 Million
407,175 New
407,175 $28.1 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $2B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.